Latest Celecoxib Stories
MUMBAI, India and BALTIMORE, December 11, 2014 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc.
Phase II Results Unveiled at 2014 American College of Rheumatology Annual Meeting TUSCALOOSA, Ala. and BOSTON, Nov.
Pfizer Canada spotlights the value of a signature in new CELEBREX ad campaign KIRKLAND, QC, Sept.
Researchers in Australia say aspirin may temporarily stave off mesothelioma in asbestos-exposed mice, but will not keep the disease from developing. Raleigh,
Mylan will launch all strengths at earliest market formation PITTSBURGH, June 2, 2014 /PRNewswire/ -- Mylan Inc.
Expects to Imminently Receive Final Approval on 50 mg Strength; Has Received Tentative Approval on All Strengths PITTSBURGH, May 30, 2014 /PRNewswire/ -- Mylan Inc.
DUBLIN, April 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S.
Mylan Seeks to Confirm Shared 180-Day Exclusivity PITTSBURGH, April 25, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has filed suit against the U.S.
The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high levels of a specific type of gene.
- A poem in which the author retracts something said in an earlier poem.